Personalized Diagnostics Reimbursement: Sometimes A Hard Sell
This article was originally published in The Gray Sheet
Two panelists at the AdvaMed 2007 meeting told different tales of gaining Medicare payment for their assays useful for personalized medicine
You may also be interested in...
Diagnostics manufacturers are urging CMS to use a more informed and transparent process to set payment rates for innovative tests
South San Francisco-based Monogram Biosciences launched its Trofile HIV diagnostic Aug. 6, timed with FDA approval of Pfizer's first-in-class HIV drug Selzentry (maraviroc) the same day
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.